EP3218489
Lifrarbólgu-B-veiru (HBV) iRNA-samsetningar og aðferðir til notkunar á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.11.2015EP published:
9.10.2019EP application number:
15797762.0
EP translation filed:
4.12.2019Grant published:
15.12.2019EPO information:
European Patent Register
Max expiry date:
9.11.2035Expiry date:
9.11.2026Next due date:
30.11.2026
Title:
HEPATITIS B VIRUS (HBV) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
Timeline
Today
10.11.2015EP application
9.10.2019EP Publication
4.12.2019Translation submitted
15.12.2019Registration published
9.11.2026Expires
Owner
Name:
Alnylam Pharmaceuticals, Inc.Address:
300 Third Street, 3rd Floor, 02142, Cambridge, MA, US
Inventor
Name:
HINKLE, GregoryAddress:
Cambridge, MA, US
Name:
SEPP-LORENZINO, LauraAddress:
Cambridge, MA, US
Name:
JADHAV, VasantAddress:
Cambridge, MA, US
Name:
MAIER, MartinAddress:
Cambridge, MA, US
Name:
MILSTEIN, StuartAddress:
Cambridge, MA, US
Name:
MANOHARAN, MuthiahAddress:
Cambridge, MA, US
Name:
RAJEEV, Kallanthottathil, G.Address:
Cambridge, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462077672 PDate:
10.11.2014Country:
US
Number:
201462077799 PDate:
10.11.2014Country:
US
Number:
201562137464 PDate:
24.3.2015Country:
US
Classification
Categories:
C12N 15/113, A61K 31/713
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 21.11.2019
Expires: 9.11.2020
Payer: Árnason Faktor
Number: 6
Paid: 20.10.2020
Expires: 9.11.2021
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 19.10.2021
Expires: 9.11.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 18.10.2022
Expires: 9.11.2023
Payer: Patice ehf.
Number: 8
Paid: 18.10.2022
Expires: 9.11.2023
Payer: Patice ehf.
Number: 9
Paid: 6.11.2023
Expires: 9.11.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 22.10.2024
Expires: 9.11.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 11.11.2025
Expires: 9.11.2026
Payer: Árnason Faktor ehf.